We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

142 hedge funds and large institutions have $576M invested in Cardiovascular Systems, Inc. in 2016 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

43% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 40

28% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 18

3% more funds holding

Funds holding: 138142 (+4)

4% more capital invested

Capital invested by funds: $552M → $576M (+$24.5M)

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

64% less call options, than puts

Call options by funds: $256K | Put options by funds: $719K

Holders
142
Holders Change
+4
Holders Change %
+2.9%
% of All Funds
3.55%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
23
Increased
57
Reduced
40
Closed
18
Calls
$256K
Puts
$719K
Net Calls
-$463K
Net Calls Change
-$991K
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$4.01M +$167K +6,785 +4%
NI
27
Numeric Investors
Massachusetts
$4M -$1.54M -62,600 -27%
Two Sigma Advisers
28
Two Sigma Advisers
New York
$3.87M +$2.44M +99,343 +164%
Goldman Sachs
29
Goldman Sachs
New York
$3.48M -$2.4M -97,683 -40%
Fidelity Investments
30
Fidelity Investments
Massachusetts
$3.34M -$9.62M -392,105 -74%
Renaissance Technologies
31
Renaissance Technologies
New York
$3.17M -$1.06M -43,000 -25%
Morgan Stanley
32
Morgan Stanley
New York
$3.17M -$374K -15,243 -10%
CIM
33
Calvert Investment Management
Maryland
$3.16M -$114K -4,626 -3%
Charles Schwab
34
Charles Schwab
California
$3.16M +$305K +12,442 +11%
Deutsche Bank
35
Deutsche Bank
Germany
$3.16M -$2.46M -100,090 -43%
Jacobs Levy Equity Management
36
Jacobs Levy Equity Management
New Jersey
$3.15M +$2.05M +83,392 +178%
EI
37
EAM Investors
California
$3.15M -$556K -22,658 -15%
PCM
38
Perkins Capital Management
Minnesota
$3.09M +$391K +15,950 +14%
USAA
39
United Services Automobile Association
Texas
$2.95M
BIM
40
BlackRock Investment Management
Delaware
$2.93M -$19.4K -790 -0.6%
HSA
41
Hussman Strategic Advisors
Maryland
$2.83M +$2.87M +117,000 New
TA
42
Teton Advisors
New York
$2.69M
Federated Hermes
43
Federated Hermes
Pennsylvania
$2.56M +$440K +17,920 +20%
BA
44
BlackRock Advisors
Delaware
$2.41M +$2M +81,671 +459%
Wells Fargo
45
Wells Fargo
California
$2.36M +$2.02M +82,498 +546%
TA
46
Teachers Advisors
New York
$2.32M +$901K +36,735 +62%
QI
47
QS Investors
New York
$2.13M +$319K +13,003 +17%
HI
48
HBK Investments
Texas
$1.99M +$766K +31,200 +61%
Allianz Asset Management
49
Allianz Asset Management
Germany
$1.94M +$1.44M +58,545 +269%
Bank of Montreal
50
Bank of Montreal
Ontario, Canada
$1.93M +$1.95M +79,559 +25,664%

CSII Hedge Fund Activity: Q4 2016 in Review

142 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2016, worth a combined $576M — up 4.4% from $552M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new CSII positions and 18 closed out — a net gain of 5 holders — while 57 added to existing stakes and 40 trimmed.

The largest buyer was Wellington Management Group, adding an estimated $12.2M. The largest seller was Camber Capital Management, cutting an estimated $12.3M.

  • 142 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2016, up from 138 in Q3 2016.
  • Funds reported $576M of Cardiovascular Systems, Inc. stock for Q4 2016, up 4.4% quarter-over-quarter.
  • 23 funds opened new Cardiovascular Systems, Inc. positions in Q4 2016 and 18 closed out, a net change of +5 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q4 2016 was Wellington Management Group, an estimated $12.2M added.
  • The largest Cardiovascular Systems, Inc. seller in Q4 2016 was Camber Capital Management, an estimated $12.3M sold.

Based on aggregated 13F filings for Q4 2016.